The 2026 EAU Guidelines on Urological Infections provide evidence-based recommendations on the diagnosis, treatment, and prevention of urinary tract infections (UTIs) and male accessory gland infections, with a focus on antimicrobial stewardship and infection control. Literature was sourced from Medline, EMBASE, and the Cochrane Library.
Key updates include a restructured classification framework for UTIs, new chapters on Herpes simplex virus and fungal UTIs, and updated evidence on periprocedural antibiotic prophylaxis for prostate biopsy. Recommendations cover antibiotic selection, dosing, and duration based on current evidence.
This is a summary/guideline document rather than a primary study, so no original patient-level data or effect sizes are reported. Recommendations depend on the quality and recency of the underlying evidence base, which is not detailed in this abstract.
Clinicians should apply the updated EAU UTI classification system and antimicrobial stewardship principles when managing urological infections. New guidance on HSV and fungal UTIs, plus revised prostate biopsy prophylaxis recommendations, should be integrated into clinical protocols.
Explore related topics
